Speaker illustration

Professor Junichi Ishii

Fujita Health University Second Hospital, Nagoya (Japan)

Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Cardiac ITU Is about the Heart, and More

Thumbnail

Circulating concentration of presepsin improves early prediction of short-term mortality in patients treated at medical cardiac intensive care units

Event: ESC CONGRESS 2019

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Acute coronary syndrome no-reflow

Thumbnail

Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure

Event: ESC Congress 2018

Topic: Biomarkers

Session: "Biomarkers reloaded": Diagnosis and prognosis of acute heart failure

Thumbnail

Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units

Event: ESC Asia with APSC & AFC 2020

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Abstract Programme

Thumbnail

This platform is supported by

logo Novo Nordisk